News
-
-
COMMUNIQUÉ DE PRESSE
Tactical Resources Announces Shareholder Approval of Arrangement With Plum Acquisition Corp. III
Tactical Resources Corp. announces overwhelming shareholder approval for business combination transaction with Plum Acquisition Corp. III, related to listing on NASDAQ in first quarter of 2026 -
COMMUNIQUÉ DE PRESSE
GMV Minerals Announces Upsize of Non-Brokered Private Placement Pursuant to the Listed Issuer Financing Exemption
GMV Minerals Inc. increases non-brokered private placement to up to C$4,550,000 due to strong investor demand. Offering includes 22,750,000 units at C$0.20 per unit. Proceeds will fund exploration of Mexican Hat Gold project -
COMMUNIQUÉ DE PRESSE
Linear Minerals Corp Closes First Tranche of Private Placement Financing
Linear Minerals Corp. closes first tranche of non-brokered private placement, issuing flow-through shares and hard-dollar units for total gross proceeds of $300,000. Proceeds will be used for working capital and exploration efforts in Quebec -
-
COMMUNIQUÉ DE PRESSE
NuRAN Announces Intention to Close the Restructuring Transaction and Additional Debt Settlements
NuRAN Wireless Inc. to close Restructuring Transaction on December 23, 2025, issuing $30M Units as described. Company also raising additional $5.5M with commitments received. Leading rural telco bridging digital divide globally -
COMMUNIQUÉ DE PRESSE
DBV Technologies Announces Positive Topline Results from Phase 3 VITESSE Trial of VIASKIN® Peanut Patch in Peanut Allergic Children Aged 4-7 Years
DBV Technologies reports positive Phase 3 VITESSE Trial results for VIASKIN Peanut Patch in children aged 4-7 years, meeting primary endpoint with notable treatment response rates and safety profile -
COMMUNIQUÉ DE PRESSE
DBV Technologies annonce des résultats préliminaires positifs dans l’étude de phase 3 VITESSE sur le patch VIASKIN® Peanut chez les enfants âgés de 4 à 7 ans allergiques à l’arachide
DBV Technologies annonce des résultats positifs dans l'étude de phase 3 VITESSE sur VIASKIN Peanut chez les enfants allergiques à l'arachide. Les critères d'évaluation sont atteints, l'innocuité est confirmée -
-
